AstraZeneca shares fall 5% on disappointing lung cancer drug trial results

AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung cancer drug trial results.

The Covid-19 vaccine maker was trading at the bottom of the FTSE 100 and dragged the wider healthcare sector lower after data published Monday showed that its experimental drug did not significantly improve overall survival results for patients.

Share were down 4.9% by 9:43 a.m. London time.

This is a breaking news story. Please check back for updates.

Source

World

U.S. pauses all immigration applications from 19 non-European countries

December 3, 2025

Travelers from Latin America and the Caribbean arrive at Miami International Airport. Carl Juste | Miami Herald | Getty Images The Trump administration on Tuesday said it paused all immigration applications, including green card and U.S. citizenship processing, filed by immigrants from 19 non-European countries, citing concerns over national security and public safety. The pause […]

World

Anthropic reportedly preparing for one of the largest IPOs ever in race with OpenAI: FT

December 3, 2025

Anthropic, the AI startup behind the popular Claude chatbot, is in early talks to launch one of the largest initial public offerings as early as next year, the Financial Times reported Wednesday. For the potential IPO, Anthropic has engaged law firm Wilson Sonsini Goodrich & Rosati, which has previously worked on high-profile tech IPOs such […]

World

CNBC Daily Open: A year-end rally is still on every trader’s wishlist

December 3, 2025

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., Nov. 26, 2025. Brendan McDermid | Reuters U.S. markets may have had a rocky start in December, but there seems to be some steam in the trading engine for a turnaround from a tumultuous November. Bitcoin recovered part […]